Economy
Financial Markets
Commodities
Industries
Energy
Real Estate
Local listed Company
Overseas-listed Company
Foreign Company
Industrial Parks


 
Stocks / IPOs
 Search News  Or
Shanghai Fosun Pharma applies for US$800-mln HK IPO

Feb. 9, 2012 (China Knowledge) - Shanghai Fosun Pharmaceutical (Group) Co<600196>, the medical subsidiary of Fosun International Ltd<0656>, China's largest privately-owned conglomerate, has submitted an application to the Hong Kong Stock Exchange for its initial public offering with fundraising between US$600 million and US$800 million.

The pharmaceutical firm's IPO is expected to be take place in the second quarter of 2012 with a size less than its original fundraising of US$1 billion due to China's bearish mainland market. The Shanghai-listed firm's A share price increased over 8% in the past one month after dropping a combined 37% in 2011.

J.P. Morgan Chase & Co, Deutsche Bank AG and China International Capital Corp have been assigned to handle the IPO.

In the third quarter of last year, Shanghai Fosun Pharmaceutical's operating revenue surged 39.17% year on year to RMB 4.63 billion, and its operating profit stood at RMB 1.39 billion, up 40.75% from a year earlier. Earnings per share for the period amounted to RMB 0.56.






Add this     
Copyright © "2015" www.chinaknowledge.com

Send feedback or comments to: news@chinaknowledge.com

For more news, financial weekly reports, business guides to China, Market Research Reports and other premium information, subscribe to China Knowledge today

To access our page on Bloomberg, type CKFI (GO)

 Our Professional Services

 E-Store

 News Archive
About Us | CSR | Media Center | E-Newsletter | E-Store | Contact Us | Feedback | Sitemap | Privacy Policy | Terms of Use  

           Copyright © 2014 China Knowledge Online. All Rights Reserved